Manuel De Lazzari

Plain English
This study looks at exercise stress testing, an important and cost-effective tool used in heart health assessments. The researchers detail how this test not only identifies heart problems caused by exercise but also provides insights about a patient's overall exercise ability and heart rhythms under stress. The findings emphasize its significance for patients with certain heart conditions or implants, helping doctors make better treatment decisions. Who this helps: This helps patients with heart issues and their doctors.

Plain English
This study looked at a specific heart imaging pattern called ring-like late gadolinium enhancement (RL-LGE) in patients with arrhythmogenic cardiomyopathy, a condition that affects the heart's ability to pump effectively. Researchers found that among 149 patients, 49% showed this pattern, especially in those with a specific genetic background. RL-LGE was linked to a higher risk of serious heart events: 24 patients experienced life-threatening issues, and 67% of those had the RL-LGE pattern, making it a significant predictor for risk. Who this helps: This research helps patients with arrhythmogenic cardiomyopathy and their doctors by identifying those at higher risk for dangerous heart events.

Plain English
This study looked at patients with heart failure affecting both sides of the heart, specifically analyzing how various health factors impact outcomes like death and hospital stays. Among 840 patients, it was found that 32.5% experienced death or hospitalization for heart failure over an average follow-up of two years, with those having diabetes experiencing higher rates (35.2% compared to 22.6%). Additionally, using ACE-inhibitors or ARBs medications significantly reduced these adverse outcomes for diabetic patients (halving their risk). Who this helps: This research benefits patients with biventricular heart failure and diabetes, as well as their doctors.

Plain English
This study examined patients with a heart condition called non-dilated left ventricular cardiomyopathy (NDLVC) to better understand their risk of life-threatening heart issues. Researchers found that out of 197 patients followed for about 2.7 years, 8% died from any cause and 4% had major heart events. Notably, when cardiologists used imaging to check for scarring in the heart, they discovered that certain patterns could indicate a higher risk of serious problems, emphasizing the value of advanced imaging in assessing patient risk. Who this helps: This research benefits doctors who treat heart patients and helps them make better decisions for those with NDLVC.

Plain English
This study looked at how microvascular obstruction (MVO) affects outcomes in heart attack patients who develop blood clots in the heart after treatment. They found that 27% of the 80 patients experienced serious heart problems during follow-up, and having a blood clot meant patients were over two and a half times more likely to have these issues, regardless of MVO levels. This is important because it highlights that heart clots signal a worse outlook for patients, which can guide doctors in treatment decisions. Who this helps: This helps patients recovering from heart attacks and their doctors.

Plain English
This study looked at how well a new cardiac imaging score (DERIVATE Risk Score 2.0) identifies patients at risk of serious heart rhythm problems in those with non-ischaemic cardiomyopathy (a type of heart disease not caused by blocked arteries). Out of 1,384 patients studied, 128 (9.2%) experienced major arrhythmic events over about 2.5 years, and factors like being male and having specific heart tissue damage helped predict these events more accurately than previous methods. This is important because it can improve the selection process for life-saving treatments like implantable defibrillators, ensuring that the right patients receive the right care. Who this helps: This research benefits patients with non-ischaemic cardiomyopathy and their doctors by guiding more targeted treatments.

Plain English
This study looks at how to better categorize heart muscle diseases, known as cardiomyopathies, by combining genetic and biological factors with how the disease affects the heart's structure and function. The researchers propose a new classification system that includes three types: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic cardiomyopathy. This matters because a clearer understanding of these diseases can lead to more tailored treatments and improved patient outcomes. Who this helps: Patients with cardiomyopathies and their doctors.

Plain English
This study looked at how to evaluate the risk of dangerous heart rhythms in people with arrhythmogenic cardiomyopathy (ACM), a heart condition that can lead to serious issues. Researchers found that using a combination of clinical exams, genetic testing, and online risk calculators can help identify patients at higher risk for complications, but doctors' expertise is still crucial in making treatment decisions. Regularly updating risk assessments is also important since ACM can change over time. Who this helps: This benefits patients with ACM and their doctors.

Plain English
This study introduces a new way to classify heart conditions known as cardiomyopathies into three main groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic. By looking at both the physical structure of the heart and the underlying biology, the researchers aim to improve how doctors diagnose and treat these conditions. This is important because better diagnosis and treatment can lead to improved health outcomes for patients with heart disease. Who this helps: This helps patients with cardiomyopathies and their doctors.

Plain English
This study looked at how using a special type of CT scan before a procedure called transvenous lead extraction (TLE) can help predict difficulties and complications during the procedure. Researchers found that complicated procedures happened in about 21% of patients, and those with fibrosis (scarring) longer than 40 mm on the CT scan were more likely to face complications. Additionally, 37% of procedures were deemed complex, with longer fibrosis lengths and lead calcifications making these procedures more challenging. The findings demonstrate that CT scans can help doctors assess risks and plan better for TLE procedures. Who this helps: This helps doctors and patients undergoing TLE by improving safety and outcomes.

Plain English
This study looked at patients who received a new type of defibrillator called a subcutaneous implantable cardioverter defibrillator (S-ICD) after their previous one (transvenous ICD, or TV-ICD) was removed due to problems like infection (64%) or lead malfunction (36%). Out of 36 patients followed for about 31 months, 8 people (22%) died, mainly from heart failure, and 7 others (19%) faced complications related to the new device. The findings show that the S-ICD is a good option for patients who need a replacement after lead extraction, with deaths primarily linked to existing health conditions rather than the new device itself. Who this helps: This helps patients requiring a defibrillator after complications from their previous device.

Plain English
This study looked at the results of 105 patients who received a subcutaneous implantable cardioverter defibrillator (S-ICD) using a specific two-incision technique over three years. The researchers found that 9.5% of patients had device-related complications and 8.5% experienced inappropriate shocks, with lead-related issues being the most frequent problems. This is important because it shows that this technique leads to few complications and effectively manages heart issues without impacting overall survival. Who this helps: This benefits patients with heart conditions who need defibrillators, as well as doctors who are implanting the devices.

Plain English
This study examined how to safely remove a specific type of heart pacing lead, known as the Medtronic 3830, from patients who had them implanted. Out of six patients, 94% of the leads were successfully extracted, and there were no major complications reported, even when special tools were required for the removal. This is important because it shows that experienced medical centers can effectively handle the removal of these leads, which may become increasingly necessary as more patients receive them. Who this helps: This helps patients with implantable heart leads, along with their doctors.

Plain English
This study looked at how to better measure heart damage (specifically, fibrosis) in patients with mitral valve prolapse (MVP), a condition that can lead to abnormal heart rhythms. Researchers evaluated 66 patients and found that 62% had fibrosis, with measurements showing that one method (the 5-SD technique) provided results closely matching a standard visual assessment. This matters because it helps standardize how doctors assess heart damage, making it easier to identify patients at risk for serious heart issues. Who this helps: This benefits patients with mitral valve prolapse and their doctors by improving diagnosis and treatment strategies.

Plain English
This study looked at how well different deep hyperthermia devices heat specific areas of the body, which is important for the effectiveness of cancer treatment. Researchers from six European institutions measured the temperature changes and heating focus of these devices after 10 minutes of heating; they found that most devices raised the temperature by 6°C and were accurate in targeting specific areas, with deviations only about 1.4 cm to 1.5 cm off from where they aimed. This research is important because it sets standards for quality checks of these devices, ensuring they work effectively and safely for patient treatments. Who this helps: Patients undergoing cancer treatment that uses hyperthermia.

Plain English
This study examined the relationship between a thinner heart muscle layer and heart function in patients with a condition called isolated left ventricular non-compaction (LVNC) cardiomyopathy. Researchers found that patients with reduced heart function (ejection fraction) had a compact heart muscle layer that was thinner compared to those with normal heart function—specifically, two or more segments of the heart wall were under 5 mm thick, which accurately identified reduced heart function with 100% sensitivity. This is important because it helps identify patients at risk for heart dysfunction based on their heart's structure. Who this helps: This helps patients with LVNC and their doctors better understand heart function and potential risks.

Plain English
This study looked at a 74-year-old man who experienced sudden chest pain after getting a pacemaker. The doctors discovered that the pacemaker had caused serious injuries, including damage to his heart and a major artery, leading to significant bleeding. They treated him successfully, and he had a good recovery over the next two years, which emphasizes the need for doctors to consider possible complications like this when patients have chest pain soon after pacemaker surgery. Who this helps: This helps doctors and patients by highlighting the risks associated with pacemaker implantation.

Plain English
This study looked at patients with advanced heart failure who used both a left ventricular assist device (LVAD) and a subcutaneous implantable cardioverter defibrillator (S-ICD). Out of 30 patients, 21 experienced some degree of electromagnetic interference, but 90% remained eligible for the S-ICD. This is important because it shows that most patients can safely use both devices together, although doctors need to be cautious about potential issues related to electromagnetic interference that could affect how the devices work. Who this helps: Patients with advanced heart failure who require mechanical support for their hearts.

Plain English
The study focused on patients with mitral valve prolapse (MVP), a heart condition that can sometimes lead to irregular heartbeats called ventricular arrhythmias (VA), even without significant valve leakage. Among 108 patients with MVP, 62 (57%) experienced VA, and those patients had more severe heart tissue and structural changes, including a longer mitral annulus disjunction (average of 6.0 mm vs. 3.2 mm) and a higher prevalence of heart tissue scarring (79% vs. 52%). This research is important because it helps identify which patients with MVP are at greater risk for serious heart issues, guiding better monitoring and treatment. Who this helps: This helps patients with mitral valve prolapse and their doctors in managing their health.

Plain English
This study looked at how often patients experienced worsening of tricuspid valve regurgitation (TR) after a procedure called transvenous lead extraction (TLE), which is used to remove implanted heart leads. Out of 158 patients, 5.7% had a significant increase in TR severity, especially those with longer lead implant durations and certain types of leads. This is important because severe worsening of TR can significantly raise the risk of dying, highlighting the need for doctors to be careful when performing this procedure. Who this helps: This helps patients undergoing lead extraction and their doctors by improving awareness of potential complications.

Plain English
This study examined a rare heart condition called left ventricular non-compaction (LVNC), which affects the structure of the heart muscle. It was found that the traditional way of diagnosing LVNC might not be specific enough, as the traits used to identify it can appear in other heart issues too. New insights suggest that the problem might actually be related to the underdevelopment of a specific part of the heart wall, which affects how well the heart pumps blood. Who this helps: This research benefits doctors and patients with heart conditions, especially those dealing with LVNC.

Plain English
This study looked at infections related to cardiac implantable electronic devices (like pacemakers) and how different factors affect patient survival. Researchers tracked 157 patients over ten years and found that infection from Staphylococcus aureus bacteria was present in 32.5% of cases, leading to worse outcomes, especially in patients with "cold closed pocket" infection patterns. They also created a scoring system to better predict mortality risk, which could help identify patients who need more aggressive treatment. Who this helps: This helps patients with cardiac device infections and their doctors in tailoring treatment strategies.

Plain English
This research paper looks at a heart condition called arrhythmogenic cardiomyopathy (ACM), which can lead to dangerous heart rhythms and sudden death. Researchers found that there are three main forms of ACM, and they've updated the criteria for diagnosing it, with cardiac magnetic resonance imaging (CMR) becoming the best way to examine the heart’s structure and function. This is important because early and accurate diagnosis can help prevent serious health issues for those affected. Who this helps: This helps patients with arrhythmogenic cardiomyopathy and their doctors.

Plain English
This study looked at how the right side of the heart performs in patients with heart failure, specifically those whose left ventricle doesn’t pump well. Researchers analyzed data from 2,449 patients and found that 38.2% had poor right ventricular function. Those with this condition had a 44% higher risk of dying from any cause, especially if they were in the early stages of heart failure or had kidney issues. Who this helps: This helps patients with heart failure and their doctors by identifying those at greater risk of complications.

Plain English
This study looked at how well machines can analyze heart scans (specifically late gadolinium enhancement MRI) to identify scar tissue in patients who have had heart attacks, and how this analysis can predict serious heart problems. In a group of 761 patients, researchers found that the machine's assessment of scar tissue was more effective at predicting major heart events than standard guidelines alone, with a difference in prediction accuracy of about 5% (0.68 compared to 0.63). This matters because it can help doctors better determine which patients need a device to prevent life-threatening heart rhythms. Who this helps: This helps patients with heart issues by improving risk assessment for serious heart events.

Plain English
This study looked at patients with a heart condition called arrhythmogenic cardiomyopathy (ACM) who received a special heart device known as the third-generation subcutaneous implantable cardioverter defibrillator (S-ICD), implanted using a new two-incision technique. Over a follow-up period of about 3.8 years, only 17.4% of the patients received at least one inappropriate shock from the device, mainly due to muscle movement during physical activity, and there was just one case of device malfunction. The findings suggest that this new implantation method is effective with a low overall complication risk, although doctors need to be aware of the potential for the device to mistakenly deliver shocks during exercise. Who this helps: This benefits patients with arrhythmogenic cardiomyopathy who need heart rhythm monitoring and treatment.

Plain English
This research paper studied a type of heart disease called scarring/arrhythmogenic cardiomyopathy (S/ACM), which affects the heart muscle by causing scarring and increases the risk of dangerous heart rhythms that can lead to heart failure. The study highlighted new diagnostic criteria that help identify this condition more accurately using advanced imaging techniques, noting that patients with S/ACM face significant risks, including ventricular dysfunction and potentially life-threatening arrhythmias. The findings emphasize the importance of medical treatment and the use of life-saving devices, like implantable cardioverter defibrillators, while noting that selecting the right patients for these devices remains a challenge. Who this helps: This helps patients with arrhythmogenic cardiomyopathy and their doctors in making better treatment decisions.

Plain English
This study focused on creating a realistic model, or "phantom," that simulates human fat tissue to improve quality checks for equipment used in hyperthermia treatment, which uses heat to target cancer cells. Researchers developed this phantom using a mixture that mimics the fat's electrical and thermal properties and confirmed it works well for testing, showing that its properties match those of human fat within a 5% margin of error. This is important because it means hospitals can better ensure their equipment is effective and safe for treating patients with cancer, especially when heating is involved. Who this helps: Patients receiving hyperthermia treatment for cancer.

Plain English
In this study, researchers looked at how effective cardiac magnetic resonance (CMR) imaging is in diagnosing heart ruptures in patients who have suffered heart attacks. They found that among 19 studied patients, those with a confirmed heart rupture had significantly higher levels of certain stress indicators in their heart tissue and showed more severe damage in heart function compared to those without ruptures. This is important because it helps identify high-risk patients and improve management of heart attack complications. Who this helps: This helps doctors and patients at risk of heart ruptures following a heart attack.

Plain English
This study looked at how effective cardiac magnetic resonance imaging (CMR) is compared to traditional heart ultrasounds (TTE) in determining who should receive an implantable cardioverter-defibrillator (ICD) to prevent sudden cardiac death in patients with weakened hearts. Of the 861 patients studied, 88 experienced serious heart-related issues during over two years of follow-up, highlighting that CMR offered better risk assessment than TTE alone. This matters because it could lead to more accurate decisions about who really needs this life-saving device, potentially improving patient outcomes. Who this helps: Patients with ischemic cardiomyopathy who are at risk of sudden cardiac death.

Plain English
This review studied how a specific imaging technique called cardiac magnetic resonance (CMR) can detect acute myocardial edema (AME), which is a sign of early heart injury. The findings suggest that when doctors identify AME early, it may indicate a better chance of recovery in patients with heart issues. For example, early detection of AME can help in cases like acute coronary syndromes and myocarditis, leading to improved patient outcomes. Who this helps: This research benefits patients with heart conditions by providing new insights into their prognosis and treatment.

Plain English
This study looked at a device called the lucite cone applicator (LCA), which is used to heat cancerous tissue during treatment. Researchers tested six LCAs to see how well they worked using updated quality guidelines. They found that the LCAs could consistently raise the temperature by over 6°C at a depth of 2 cm, indicating they performed well according to established standards, with minor differences in results when compared to computer simulations. Who this helps: Patients undergoing superficial hyperthermia treatment for cancer.

Plain English
This study looked at how well cardiovascular magnetic resonance (CMR) imaging works for patients with certain heart devices like pacemakers and defibrillators. Out of 309 scans from 292 patients, 83% were completed successfully, and most scans (68%) had good image quality. The findings indicate that CMR is safe for these patients and can provide valuable diagnostic information, despite some issues with image quality caused by the devices. Who this helps: This benefits patients with heart devices and their doctors by providing safer and more reliable imaging options.

Plain English
This study looked at how a new measurement called the left atrial expansion index (LAEI) can help estimate pulmonary capillary wedge pressure (PCWP) in patients with dilated cardiomyopathy (DCM). Researchers found that LAEI had a strong link to PCWP, accurately identifying cases with a PCWP equal to or greater than 15 mmHg with 82.4% sensitivity and 88.2% specificity, making it a reliable non-invasive option for evaluation. This is important because it could make it easier for doctors to monitor heart function in DCM patients without needing invasive procedures. Who this helps: Patients with dilated cardiomyopathy and their doctors.

Plain English
This study focused on how well isoprenaline works for patients with unstable third-degree atrioventricular block, a serious heart condition that can lead to fainting or even death. Researchers found that isoprenaline was effective for 84% of patients, compared to only 31% for dopamine, making isoprenaline a much better option. This is important because it suggests a safer and more effective treatment while waiting for a permanent pacemaker, which can significantly improve patient outcomes. Who this helps: This benefits patients experiencing unstable heart conditions and their doctors.

Plain English
This study examined the success and safety of removing old heart leads using special tools in patients whose leads had been in place for more than 10 years. Out of 441 leads from 189 patients, 94.8% were completely removed successfully, with only 1.8% failing to be extracted and a low complication rate of 2%. These results are important because they show that lead extraction can be done safely and effectively in older patients who need it, which can improve their health and reduce complications. Who this helps: This benefits patients with old heart leads and their doctors.

Plain English
This study looked at the outcomes of a procedure called transvenous lead extraction (TLE) in patients aged 80 and older, specifically using advanced tools to help with the process. Out of 83 patients, the procedure was successful in 93.9% of cases, with a 30-day mortality rate of 6%. The findings show that, although older patients have higher risks of complications, the extraction can be done safely and effectively using specialized methods, helping doctors make better decisions about heart device removals for this age group. Who this helps: This research benefits elderly patients with heart devices, as well as their healthcare providers.

Plain English
This study looked at a 16-year-old boy who developed shortness of breath when active, which is a condition called exertional dyspnea, after having a chest injury from a motorbike accident two years prior. Despite having no other health issues or family history of heart problems, he experienced significant difficulty during physical activities, rated as Class II-III on a common scale for heart-related symptoms. Understanding these symptoms is important because they may indicate that previous injuries can have lasting effects on young people's heart and lung function. Who this helps: This information benefits young patients recovering from chest injuries and their doctors.

Plain English
This study focuses on a heart disease called arrhythmogenic cardiomyopathy (ACM), which can lead to serious issues like sudden cardiac death. Researchers identified limitations in the old diagnostic criteria, mainly how poorly they detected problems in the left side of the heart. The new 2020 Padua criteria improve diagnosis by better recognizing left ventricular issues and incorporating advanced imaging techniques, allowing doctors to categorize ACM into three types based on which side of the heart is more affected. Who this helps: This helps patients with arrhythmogenic cardiomyopathy and their doctors by providing clearer guidelines for diagnosis and treatment.

Plain English
This study looked at how the COVID-19 pandemic impacted patients with implantable cardioverter defibrillators (ICDs) who were monitored remotely instead of in person. Researchers found that the rate of serious heart events and deaths for these patients in 2020 was similar to 2019, with 10% experiencing incidents in both years. While there was a slight rise in deaths from 2.8% to 4.6% in 2020, this wasn't statistically significant, indicating that remote monitoring effectively maintained patient care during the pandemic. Who this helps: This research benefits patients with ICDs and their healthcare providers by showing that remote monitoring can be a reliable option during crises like a pandemic.

Plain English
This study looked at patients with Brugada syndrome who had a device called an implantable cardioverter defibrillator (ICD) to prevent dangerous heart rhythms. Out of 105 patients followed for about five years after their device replacement, 10 (or 9%) experienced serious heart issues that required intervention from the ICD. The research found that patients with a specific heart rhythm pattern (an S-wave in lead I) were much more likely to have these serious events, indicating that their condition may require extra attention. Who this helps: This helps patients with Brugada syndrome and their doctors by identifying specific risks that can guide treatment.

Plain English
This study looked at how to safely remove large infections (called vegetations) from heart device leads in patients with a condition known as cardiac device-related infective endocarditis. Researchers used a technique called the AngioVac system and found that it successfully removed over 70% of the infections in 12 out of 13 patients, with only one patient experiencing a serious complication. This approach is important because it provides a safer and effective alternative to traditional surgery for patients with these large infections. Who this helps: This benefits patients with infected heart devices and their doctors.

Plain English
This study looked at what factors predict late heart rhythm problems in patients with Brugada syndrome who had a device implanted to prevent dangerous heart rhythms. The research found that specific indicators can help identify patients at higher risk for these complications. This is important because it allows doctors to monitor and manage these patients more effectively. Who this helps: This helps patients with Brugada syndrome and their doctors.